Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept dosing regimens for nail and plaque psoriasis
2006-004453-18Phase 4Completed
- Sponsor
- Wyeth
- Start
- Apr 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of etanercept in nail psoriasis and plaque psoriasis (2 arms), sponsored by Wyeth. Started Apr 2007; status: completed.
02
Drugs
etanercept
03
Conditions
nail psoriasisplaque psoriasis
Beyond the preview
Go deeper on 2006-004453-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004453-18.